Genmab A-S
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $6,722,821 | $1,022,000 | $5,861,743 | $715,000 |
Gross Profit | 6,208,125 | 964,000 | 5,500,533 | 673,000 |
EBITDA | 1,544,088 | 503,000 | 2,838,984 | 265,000 |
EBIT | 485,000 | 2,737,592 | 249,000 | |
Net Income | 196,982 | 401,000 | 2,129,238 | 195,000 |
Net Change In Cash | 6,722,821 | 1,022,000 | 5,861,743 | 715,000 |
Free Cash Flow | 1,831,432 | 534,000 | 329,525 | 1,746,155 |
Cash | 10,905,590 | 1,761,000 | 8,212,777 | 8,212,777 |
Basic Shares | 672,593 | 620,743 | 619,926 | 639,340 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $23,728,068 | $21,526,000 | $16,474,000 | $14,505,000 |
Gross Profit | 21,757,107 | 20,541,000 | 16,248,000 | 14,505,000 |
EBITDA | 8,426,015 | 9,697,000 | 5,947,000 | 7,346,000 |
EBIT | 7,973,141 | 9,284,000 | 5,707,000 | 6,984,000 |
Net Income | 6,142,507 | 7,844,000 | 4,352,000 | 5,452,000 |
Net Change In Cash | 23,728,068 | 21,526,000 | 16,474,000 | 14,505,000 |
Free Cash Flow | 7,328,911 | 7,584,000 | 7,004,000 | 3,595,000 |
Cash | 10,905,590 | 9,858,000 | 14,867,000 | 9,893,000 |
Basic Shares | 626,916 | 646,330 | 659,150 | 660,100 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0.21 |
2025-09-30 | $0.65 |
2025-06-30 | $0.54 |
